Carillon Tower Advisers’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-52,100
Closed -$10.9M 476
2020
Q3
$10.9M Sell
52,100
-20,525
-28% -$4.57M 0.15% 242
2020
Q2
$15.9M Sell
72,625
-35,175
-33% -$7.03M 0.12% 233
2020
Q1
$18.7M Buy
+107,800
New +$17.8M 0.18% 179
2019
Q2
Sell
-86,550
Closed -$13.9M 469
2019
Q1
$13.9M Buy
86,550
+29,750
+52% +$4.62M 0.1% 288
2018
Q4
$8.76M Sell
56,800
-60,700
-52% -$9.46M 0.07% 321
2018
Q3
$17.7M Buy
117,500
+8,350
+8% +$1.19M 0.13% 251
2018
Q2
$14.8M Buy
109,150
+49,450
+83% +$6.1M 0.12% 265
2018
Q1
$7.95M Buy
+59,700
New +$8.02M 0.06% 326

Other funds holding CLX

Carillon Tower Advisers's CLX Position: Q4 2020 in Review

Carillon Tower Advisers sold out of Clorox (CLX) in Q4 2020, closing a stake of 52,100 shares — an estimated $10.9M sold.

Carillon Tower Advisers first reported a position in CLX in Q1 2018 and held it in 8 quarters. The position peaked at $18.7M in Q1 2020. 1,264 funds tracked by Wall St. Rank hold CLX as of Q4 2020.

  • Carillon Tower Advisers reported no remaining Clorox position as of Q4 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 52,100 Clorox shares in Q4 2020, an estimated $10.9M.
  • Carillon Tower Advisers first reported a position in Clorox in Q1 2018 and held it in 8 quarters.
  • Carillon Tower Advisers's Clorox position peaked at $18.7M in Q1 2020.
  • 1,264 funds tracked by Wall St. Rank held Clorox as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.